PSTV PLUS THERAPEUTICS, INC.

Nasdaq Surgical & Medical Instruments & Apparatus DE CIK: 0001095981
AI RATING
STRONG_SELL
92% Confidence

Investment Thesis

PSTV faces severe financial distress with -$7.1M operating loss on only $1.0M revenue (-10.5% YoY) and -$6.2M operating cash burn. With $3.0M cash against ~$7M annual burn rate, the company has critical liquidity runway of less than 6 months. While gross margin of 40.1% suggests product viability, the company is destroying shareholder value (-58.1% ROE) with no visible profitability trajectory.

Strengths

  • + Gross margin of 40.1% indicates product-level unit economics and pricing power
  • + Current ratio of 2.27x and quick ratio of 2.25x provide near-term liquidity buffer
  • + Moderate leverage at 0.32x debt-to-equity limits immediate refinancing pressure

Risks

  • ! Critical cash runway: $3.0M cash against $7.1M annual burn rate equals ~5 months survival
  • ! Revenue declining 10.5% YoY despite fundamental need to scale operations
  • ! Massive operating losses with -692.5% operating margin and negative 116.7x interest coverage
  • ! Negative returns destroying equity (-58.1% ROE, -34.9% ROA) with no profitability roadmap
  • ! Limited debt/equity capacity to raise capital given current financial performance

Key Metrics to Watch

Financial Metrics

Revenue
1.0M
Net Income
-6.9M
EPS (Diluted)
$-1.05
Free Cash Flow
-7.1M
Total Assets
19.9M
Cash
3.0M

Profitability Ratios

Gross Margin 40.1%
Operating Margin -692.5%
Net Margin -675.7%
ROE -58.1%
ROA -34.9%
FCF Margin -686.4%

Balance Sheet & Liquidity

Current Ratio
2.27x
Quick Ratio
2.25x
Debt/Equity
0.32x
Debt/Assets
39.9%
Interest Coverage
-116.70x
Long-term Debt
3.8M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-31T07:40:26.628947 | Data as of: 2026-03-31 | Powered by Claude AI